Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses
- PMID: 6606671
Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses
Abstract
Binding of radioiodinated vasoactive intestinal peptide (VIP) to mouse lymphocytes has been investigated. Specific cell binding of 125I-VIP was demonstrated with lymphocytes from mesenteric lymph nodes, subcutaneous lymph nodes, spleen, and Peyer's patches. The binding of VIP by these cells was accounted for by VIP binding sites upon T cells rather than non-T cells. In the presence of VIP, the in vitro response of lymphocytes to the T cell mitogens concanavalin A (Con A) and phytohemagglutinin (PHA) was inhibited in a dose-dependent fashion, whereas that to the B cell mitogen lipopolysaccharide (LPS) was not. There was a close correlation between the potency of VIP and some structurally related peptides for inhibition of 125I-VIP binding and the effect of those peptides on T cell mitogen responses. These observations demonstrate that mouse T lymphocytes have specific VIP receptors and that VIP can modulate the response of T cells to mitogenic stimulation. VIP may be an important immunoregulatory molecule, and may be implicated in the regulation of T cell function in mucosal tissues innervated by VIP-containing neurons.
Similar articles
-
Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.Immunology. 1987 Oct;62(2):291-7. Immunology. 1987. PMID: 2960611 Free PMC article.
-
Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.J Immunol. 1986 Jan;136(1):152-6. J Immunol. 1986. PMID: 2415614
-
Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.Cell Immunol. 1993 Jun;149(1):11-23. doi: 10.1006/cimm.1993.1132. Cell Immunol. 1993. PMID: 8099848
-
Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine, and immune systems.Fed Proc. 1987 Jan;46(1):192-5. Fed Proc. 1987. PMID: 3026856 Review.
-
Role of vasoactive intestinal peptide in inflammation and autoimmunity.Curr Opin Investig Drugs. 2005 Nov;6(11):1116-23. Curr Opin Investig Drugs. 2005. PMID: 16312132 Review.
Cited by
-
VIP: molecular biology and neurobiological function.Mol Neurobiol. 1989 Winter;3(4):201-36. doi: 10.1007/BF02740606. Mol Neurobiol. 1989. PMID: 2698176 Review.
-
Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.Clin Exp Immunol. 1992 Mar;87(3):504-8. doi: 10.1111/j.1365-2249.1992.tb03027.x. Clin Exp Immunol. 1992. PMID: 1311995 Free PMC article.
-
Distribution of somatostatin-immunoreactive nerve fibres in Peyer's patches.Gut. 1992 Sep;33(9):1195-8. doi: 10.1136/gut.33.9.1195. Gut. 1992. PMID: 1358766 Free PMC article.
-
Without nerves, immunology remains incomplete -in vivo veritas.Immunology. 2005 Oct;116(2):145-63. doi: 10.1111/j.1365-2567.2005.02223.x. Immunology. 2005. PMID: 16162264 Free PMC article. Review.
-
Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells.Brain Behav Immun. 2008 Oct;22(7):1024-1031. doi: 10.1016/j.bbi.2008.04.006. Epub 2008 Jun 13. Brain Behav Immun. 2008. PMID: 18555660 Free PMC article.